About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction

NCT03001284·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Carol Davila University of Medicine and Pharmacy

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

1. age between 18 and 65 years;
2. patients with confirmed MS diagnosis, both newly diagnosed or already under immunomodulatory treatment;
3. informed consent signed.

You may not be if

1. MS treated with mitoxantrone;
2. patients with known cardiovascular disease;
3. presence of other neurological conditions;
4. any renal, pulmonary, hepatic or hematological disease;
5. diabetes mellitus;
6. any degree of arterial hypertension;
7. pregnancy;
8. and difficult acoustic window

The record

StatusUnknown

PhaseNo phase

Taking part103

StartedOct 2012

UpdatedDec 23, 2016

Conditions

Multiple Sclerosis

Clareo Health | Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction